Address
Shire PLC
5 Riverwalk
Citywest Business Campus
Dublin
Co. Dublin
Ireland
Website
Sector
Recent investment activity
KANDO id: 14395711
Corporate information
Official name
Shire PLC
Overview
Shire enables people with life-altering conditions to lead better lives. Shire's strategy is to focus on developing and marketing innovative specialty medicines to meet significant unmet patient needs. Shire's focus is on providing treatments in Rare Diseases, Neuroscience, Gastrointestinal and Internal Medicine and we are developing treatments for symptomatic conditions treated by specialist physicians in other targeted therapeutic areas, such as Ophthalmics.
Funding rounds
Acquisition USD 54,800,000,000
USD 54,800,000,000 ( ) at USD 54,800,000,000 pre-money valuation
ABANDONED
Investor | Profile | Country | Notes | |
---|---|---|---|---|
Abbvie Inc | USD 54,800,000,000 (USD 54,800,000,000) Initial investment. |
Actual initial investment stage
Acquisition (1)
Investment activity status
Active investor
Selected investments
Displaying 1 - 1 of 1Company | Profile | Country | Date | Funding | ||
---|---|---|---|---|---|---|
ViroPharma Inc | Provider of life-saving medicines for life-threatening diseases. | Acquisition Initial investment led the round USD 4,200,000,000 (USD 4,200,000,000) |